# A Randomized, Double-blinded Placebo-controlled Study to Investigate Antimicrobial Efficacy and Safety Following Topical Application of DPK-060

> **NCT01522391** · PHASE1,PHASE2 · COMPLETED · sponsor: **DermaGen AB** · enrollment: 41 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** DPK-060 1% ointment
- **DRUG:** Placebo for DPK-060 ointment

## Key facts

- **NCT ID:** NCT01522391
- **Lead sponsor:** DermaGen AB
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2009-04
- **Final completion:** 2009-04
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2018-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01522391

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01522391, "A Randomized, Double-blinded Placebo-controlled Study to Investigate Antimicrobial Efficacy and Safety Following Topical Application of DPK-060". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01522391. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*